MEREDITH SILER: Open Payments
NPI 1699430686 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,854 in 143 payments from 19 companies in 2025. Trend: 2023 $1,670 · 2024 $2,017 · 2025 $2,854
Food & beverage: $2,811Education: $43
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 25 | $484 |
| AstraZeneca Pharmaceuticals LP | 22 | $454 |
| JAZZ PHARMACEUTICALS INC. | 18 | $269 |
| Regeneron Healthcare Solutions, Inc. | 13 | $239 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $215 |
| GENZYME CORPORATION | 10 | $187 |
| Axsome Therapeutics, Inc. | 6 | $179 |
| Insmed, Inc. | 8 | $158 |
| Viatris Specialty LLC | 7 | $144 |
| Verona Pharma, Inc. | 6 | $130 |
Products named: DUPIXENT, NUCALA, XYWAV, Sunosi, OFEV, Arikayce, YUPELRI, Ohtuvayre.
Industry payments across NC — which companies pay providers there.
